SU6656 structure
|
Common Name | SU6656 | ||
---|---|---|---|---|
CAS Number | 330161-87-0 | Molecular Weight | 371.453 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C19H21N3O3S | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A |
Use of SU6656SU 6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. |
Name | su 6656 |
---|---|
Synonym | More Synonyms |
Description | SU 6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C19H21N3O3S |
Molecular Weight | 371.453 |
Exact Mass | 371.130371 |
PSA | 90.65000 |
LogP | 3.46 |
Index of Refraction | 1.657 |
Storage condition | -20℃ |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | N |
RIDADR | NONH for all modes of transport |
Prolonged continuous in vitro human platelet production using three-dimensional scaffolds.
Exp. Hematol. 37(1) , 101-10, (2009) Methods producing human platelets using growth on plastic, on feeder layers, or in suspension have been described. We hypothesized that growth of hematopoietic progenitors in a three-dimensional (3D) ... |
|
Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.
Nat. Commun. 5 , 5092, (2014) Ovarian cancer is the most lethal gynaecologic malignancy in the United States, and advanced serous ovarian adenocarcinoma is responsible for most ovarian cancer deaths. However, the stroma-derived mo... |
|
Effects of tyrosine phosphorylation of cortactin on podosome formation in A7r5 vascular smooth muscle cells.
Am. J. Physiol. Cell Physiol. 290(2) , C463-71, (2006) Cortactin, a predominant substrate of Src family kinases, plays an important role in Arp2/3-dependent actin polymerization in lamellipodia and membrane ruffles and was recently shown to be enriched in... |
1H-Indole-5-sulfonamide, 2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-, (3Z)- |
(3Z)-N,N-Dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)-5-indolinesulfonamide |
(3Z)-N,N-Dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)indoline-5-sulfonamide |
SU6656 |